SynthesisMedicine2019

Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.

Dapeng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.